Latest Blog in: Opinion


Opinion

DEMONS FROM THE SHADOWS - Nitazenes, Cartel Chemists, and the Darkest Possible End of the Drug War

by Reginald Reefer | Saturday Feb 28, 2026

In the first piece, I argued that the United States is losing a chemical war with China, and that the only asymmetric counter-strategy with any historical precedent for success is domesticating the drug supply — legalizing the agrarian, organic substances that humans have used for millennia, regulating them intelligently, and stripping the cartels of their customer base through market competition.

Opinion

The Curious Case of Cannabis and Autism: The Data Your Doctor Isn't Telling You About

by Reginald Reefer | Wednesday Feb 25, 2026

Here's something that should fundamentally change how we think about autism and cannabis: autistic children have significantly reduced plasma levels of endocannabinoids. The endocannabinoid system (ECS) is a ubiquitous neuromodulatory network that regulates socioemotional responses, cognition, seizure susceptibility, pain perception, and neuronal plasticity. In other words, it governs precisely the areas where autistic individuals struggle most.

Opinion

How Legalizing Organic Drugs Is the Only Way to Win America's Chemical War with China

by Reginald Reefer | Tuesday Feb 24, 2026

The pharmacological difference between natural THC and synthetic cannabinoids like K2 is the difference between a partial agonist and a full agonist. THC, the active compound in cannabis, partially activates the CB1 receptor in your brain. There is a biological ceiling on how activated that receptor can get from natural cannabis. This is why a fatal marijuana overdose is, for all practical purposes, impossible.

Opinion

The Cannabis Psychosis Paradox: Why Society Fears the Wrong Things

by Reginald Reefer | Monday Feb 23, 2026

Here's the reality that gets buried under every sensationalized headline about "marijuana-induced madness": the baseline annual incidence of psychotic disorders in the general population is approximately 0.0027%. That's 2.7 cases per 100,000 people. You have better odds of being struck by lightning. Now, when we factor in cannabis use, even among daily users of high-potency products, that risk climbs to somewhere between 0.008% and 0.011% annually. Over a ten-year period, we're talking about a cumulative risk of 0.08% to 0.11%.

Opinion

Why Economists Can't Understand Why Kids Get High: The Tax Deterrence Delusion

by Reginald Reefer | Thursday Feb 19, 2026

Enter a recent study from the Learned Societies Trust that asks: "Can taxation be used to effectively limit young people's use of legalized marijuana?" The research, conducted by Michelle Sovinsky, observes that young people tend to use marijuana, alcohol, and cigarettes in combination. The conclusion? If we increase taxes on alcohol and cigarettes, we can reduce marijuana use among youth.

Opinion

Schedule III Was Always a Trap: US Congressman Finally Says the Quiet Truth Out Loud

by Reginald Reefer | Tuesday Feb 17, 2026

Congressman Andy Harris just told you exactly what Schedule III rescheduling is: a 20-year stalling tactic designed to run out the clock on marijuana legalization. He said the quiet part out loud, and we should thank him for the honesty. This isn't about science. It isn't about safety. It isn't about protecting children or public health or any of the other rhetorical bullshit they've been feeding us for 87 years.

Opinion

The New York Times Wants You to Believe America has a Marijuana Problem

by Reginald Reefer | Sunday Feb 15, 2026

The New York Times wants you to believe America has a marijuana problem. I want you to believe the New York Times has an integrity problem. In February 2026, the editorial board of what's supposedly America's "paper of record" published a breathtaking reversal of their decade-old position on cannabis legalization. The headline might as well have been written by Kevin Sabet himself: essentially declaring that marijuana legalization was a "mistake" requiring "sober reassessment."

Opinion

The Arbitrary Legal Threshold of 0.3% Delta-9 THC - Why It's Time to Stop Pretending Hemp and Marijuana are Different

by Reginald Reefer | Wednesday Feb 11, 2026

Hemp and marijuana are the same plant. Scientifically, legally, botanically—it's all Cannabis sativa L. The only difference is an arbitrary legal threshold of 0.3% delta-9 THC content. Below that line? Legal hemp. Above it? Schedule I controlled substance, sitting right next to heroin.

Opinion

CBD Amplifies the Effects of THC Claims New Medical Study

by Reginald Reefer | Saturday Feb 7, 2026

A recent study published in the journal Clinical Pharmacology and Therapeutics is challenging this long-held belief. Contrary to popular opinion, the research suggests that CBD may actually intensify the effects of THC, not dampen them. This revelation is sending ripples through the cannabis community and forcing us to reconsider our understanding of how these cannabinoids interact.

Opinion

THC Beverages and the Billion-Dollar Panic: Why Alcohol Companies Are Funding Your Favorite Prohibitionist

by Reginald Reefer | Friday Feb 6, 2026

A recent study published in the International Journal of Drug Policy examined the drinking habits of cannabis beverage consumers and found something the alcohol industry has been dreading for years—people who consume THC-infused drinks report significant reductions in their alcohol consumption. We're not talking about a negligible dip. We're talking about people actively substituting a non-toxic, non-addictive substance (cannabis) for one of the most dangerous drugs legally available (alcohol).